Number of the records: 1  

Enzybiotics LYSSTAPH-S and LYSDERM-S as Potential Therapeutic Agents for Chronic MRSA Wound Infections

  1. 1.
    SYSNO ASEP0531787
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleEnzybiotics LYSSTAPH-S and LYSDERM-S as Potential Therapeutic Agents for Chronic MRSA Wound Infections
    Author(s) Vacek, L. (CZ)
    Kobzová, Š. (CZ)
    Čmelík, Richard (UIACH-O) RID
    Pantůček, R. (CZ)
    Janda, L. (CZ)
    Number of authors5
    Article number519
    Source TitleAntibiotics (Basel). - : MDPI - ISSN 2079-6382
    Roč. 9, č. 8 (2020)
    Number of pages16 s.
    Publication formPrint - P
    Languageeng - English
    CountryCH - Switzerland
    Keywordsenzyme therapy ; enzybiotics ; lysostaphin
    Subject RIVCB - Analytical Chemistry, Separation
    OECD categoryAnalytical chemistry
    Method of publishingLimited access
    Institutional supportUIACH-O - RVO:68081715
    UT WOS000564568700001
    EID SCOPUS85089651431
    DOI10.3390/antibiotics9080519
    AnnotationAntistaphylococcal enzymes derived from lysostaphin and endolysin were modified in order to improve their antimicrobial properties and stability. These antimicrobial enzymes proved to be efficient in killing of the diverse strains of methicillin-resistant Staphylococcus aureus.
    WorkplaceInstitute of Analytical Chemistry
    ContactIveta Drobníková, drobnikova@iach.cz, Tel.: 532 290 234
    Year of Publishing2021
    Electronic addresshttp://hdl.handle.net/11104/0310404
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.